These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14533998)

  • 1. [Sildenafil as a substitute for subcutaneous prostacyclin in pulmonary hypertension].
    Cea-Calvo L; Escribano Subías P; Tello de Menesses R; Gómez Sánchez MA; Delgado Jiménez JF; Sáenz de la Calzada C
    Arch Bronconeumol; 2003 Oct; 39(10):476-7. PubMed ID: 14533998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sildenafil effective in secondary pulmonary hypertension due to systemic lupus erythematosus? A case report.
    Hanta I; Demir M; Akpinar O; Kocabas A; Ozbek S
    Clin Rheumatol; 2005 Nov; 24(6):671-2. PubMed ID: 15951919
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.
    Gomberg-Maitland M; McLaughlin V; Gulati M; Rich S
    Am J Cardiol; 2005 Nov; 96(9):1334-6. PubMed ID: 16253609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked improvement with sildenafil in a patient with idiopathic pulmonary arterial hypertension unresponsive to beraprost and sarpogrelate.
    Kawano H; Sengyoku H; Satoh O; Urabe S; Koide Y; Yano K
    Intern Med; 2007; 46(12):893-8. PubMed ID: 17575385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary pulmonary hypertension: prospects for treatment].
    Sáenz de la Calzada C
    Med Clin (Barc); 2004 Jan; 122(2):62-3. PubMed ID: 14733858
    [No Abstract]   [Full Text] [Related]  

  • 7. Sildenafil treatment of primary pulmonary hypertension.
    Laupland KB; Helmersen D; Zygun DA; Viner SM
    Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of rebound pulmonary hypertension: why not sildenafil?
    Raja SG
    Anesthesiology; 2004 Dec; 101(6):1480; author reply 1481. PubMed ID: 15564966
    [No Abstract]   [Full Text] [Related]  

  • 10. Phosphodiesterase inhibitors in the management of primary pulmonary hypertension.
    Jue VI
    Prog Cardiovasc Nurs; 2004; 19(2):74-9. PubMed ID: 15133384
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic lupus erythematosus-associated pulmonary hypertension: good outcome following sildenafil therapy.
    Molina J; Lucero E; Luluaga S; Bellomio V; Spindler A; Berman A
    Lupus; 2003; 12(4):321-3. PubMed ID: 12729058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
    Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
    Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
    Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation.
    Saggar R; Shapiro SS; Ross DJ; Fishbein MC; Zisman DA; Lynch JP; Weigt SS; Ardehali A; Belperio JA; Saggar R
    J Heart Lung Transplant; 2009 Sep; 28(9):964-7. PubMed ID: 19716051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of a pharmacokinetic interaction between treprostinil diolamine and sildenafil in healthy adult volunteers.
    Gotzkowsky SK; Kumar P; Mottola D; Laliberte K
    J Cardiovasc Pharmacol; 2013 May; 61(5):444-51. PubMed ID: 23429588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined treatment with intravenous prostacyclin and sildenafil in patients with pulmonary hypertension: report of 4 cases].
    García Hernández FJ; Ocaña Medina C; Mateos Romero L; Martínez Martínez A; Bautista Lorite A; Santos Ramos B; Sánchez Román J
    Med Clin (Barc); 2004 Jan; 122(2):64-6. PubMed ID: 14733859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil in secondary pulmonary hypertension.
    Cubillos-Garzón LA; Casas JP; Morillo CA
    Int J Cardiol; 2003 May; 89(1):101-2. PubMed ID: 12727014
    [No Abstract]   [Full Text] [Related]  

  • 18. Marked improvement with sildenafil in a patient with primary pulmonary hypertension unresponsive to epoprostenol.
    Kataoka M; Satoh T; Manabe T; Anzai T; Yoshikawa T; Mitamura H; Ogawa S
    Intern Med; 2004 Oct; 43(10):945-50. PubMed ID: 15575245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil as a treatment for pulmonary hypertension.
    Carroll WD; Dhillon R
    Arch Dis Child; 2003 Sep; 88(9):827-8. PubMed ID: 12937112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension.
    Wang YW; Lin HC; Yang YY; Hou MC; Lee SD
    J Gastroenterol; 2006 Jun; 41(6):593-7. PubMed ID: 16868809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.